-
Uncategorized3 weeks ago
Lilly Builds Differentiated Profile for Triple-G Agonist With Late-Stage Diabetes Data
Eli Lilly’s retatrutide could present a “differentiated option” for patients with type 2 diabetes who want to control their blood sugar and achieve maximal weight loss,...
-
AI & Machine Learning in Biotechnology3 weeks agoSTAT+: Pharmalittle: We’re reading about a Lilly weight loss trial, TrumpRx shortcomings, and more
Top of the morning to you, and a fine one it is. Despite dreary, gray skies and chilly temperatures, the Pharmalot campus is humming with activity,...
-
Biotech Industry Intelligence3 weeks ago
Washington’s Medicaid program will pay for ElliQ, an AI robot for loneliness
Washington’s Medicaid program will pay for ElliQ, an AI robot for loneliness
-
Biotech Industry Intelligence3 weeks ago
GSK liver drug wins FDA approval
GSK liver drug wins FDA approval
-
Fierce Biotech3 weeks ago
Pfizer adds to Seagen scrap heap with another early cancer candidate cull
About a month after Pfizer CEO Albert Bourla, Ph.D., told investors that the Big Pharma’s pipeline pruning was mostly done, the company has trimmed another branch....
-
Uncategorized3 weeks agoFDA grants Fast Track Designation to rare disease treatment
The US Food and Drug Administration (FDA) has granted Fast Track Designation to a treatment for the rare paediatric disease late-infantile neuronal ceroid lipofuscinosis (LINCL/CLN2 disease). ...
-
Biotech Industry Intelligence3 weeks ago
Gossamer Nearly Halves Workforce in Savings Push After Late-Stage Hypertension Fail
Gossamer Nearly Halves Workforce in Savings Push After Late-Stage Hypertension Fail
-
Uncategorized3 weeks agoGenomics initiative could boost AI-designed therapeutics
A new initiative is set to generate and model biological data at the trillion-gene scale, paving the way to scale AI-designed therapeutics. The Trillion Gene Atlas,...
-
BioPharma Dive – AI / Data3 weeks agoAstraZeneca to boost cell therapy capabilities with new China investment
The planned Shanghai facility extends a yearslong push into the field and will support CAR-T therapies AstraZeneca is making for autoimmune disease and cancer.
-
ScienceDaily – Biotechnology3 weeks ago
Scientists discover tiny rocket engines inside malaria parasites
Malaria parasites contain tiny spinning crystals that have puzzled scientists for years. New research reveals they’re powered by a rocket-like reaction that breaks down hydrogen peroxide,...
Sanofi Bispecific Scores in Asthma, Rhinosinusitis, but Eczema Bet Doesn’t Pay Off
